子宫内膜癌相关的肿瘤标志物的研究进展

澄 张(新乡医学院第一附属医院，中国)
君 杨(新乡医学院第一附属医院，中国)

摘要

子宫内膜癌作为女性生殖系统发病率较高源自上皮细胞的恶性肿瘤，多见于绝经后女性，约占女性生殖系统恶性肿瘤发病率的 20%-30%。近年来，子宫内膜癌患病女性逐渐趋于年轻化，且发病率呈明显上升趋势，成为发病率仅此于宫颈癌的女性生殖系统恶性肿瘤。为了提高患者的生存质量及改善患者预后，早发现、早诊断、早治疗显得尤其重要。近年来，肿瘤标志物越来越多的被应用在恶性肿瘤的诊断中，论文对与子宫内膜癌相关的肿瘤标志物的研究及进展情况做一综述。

关键词

子宫内膜癌；肿瘤标志物；研究进展

参考

Ferlay J, Soer jomataram I, Ervik M, etal. Cancer Incidence and Mortality Worldwide[J].Agency for Research on Cancer,2013(09):111-114.

Brinton LA,Felix AS,McMeekin DS,etal.Etiologic hetero-geneity in endometrial cancer:evidence from a Gynecologic Oncology Group trial[J].Gynecol Oncol,2013(02):277-284.

Guo M.Wang XD.Li FH.Significance of combined detection of human epididymal secretory protein 4 and carbohydrate antigen 125 in diagnosing pelvictumor[J].Int J Lab Med,2014(05):523-524.

C.Kirchhoff,I.Habben,R.Ivell.A major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors[J].Biol.Reprod,1991(02):350-357.

R.G.Moore,A.K.Brown,M.C.Miller.Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adeno carcinoma of the uterus,Gynecol[J].Oncol,2008(02):196-201.

Nozaki K,Ogawa M,Williams IA,etal.A molecular signature of gastric metaplasia arising in response to acute parietal cell loss[J].Gastroente rology,2008(02):511-522.

Hough CD,Sherm an Baust CA,Pizer ES,etal.Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer[J].Cancer Res,2000(22):6281-6287.

Li J,Dowdy S,Tipton T,etal.HE4 as a biomarker for ovarian andendometrial cancer management[J].Expert Rev MolDiagn, 2009(06):555-566.

Li X,Gao Y,Tan M,etal.Expression of HE4 in Endometrial Cancer and Its Clinical Significance[J].Biomed Res Int,2015(03):437-468.

Deng L,Gao Y,Li X,etal.Expression and clinical significance of annexin A2 and human epididymis protein 4 in endometrial carcinoma[J].Exp Clin Cancer Res,2015(34):96.

赵莹珺 , 杨剑峰 , 朱景德 . 人卵巢癌相关候选基因 HE4（ WFDC2）的转录调控主要由 SP1 与位于 271 和 248 的 Egr21 位点结合所介导 [J]. 肿瘤 ,2004(06):517-525.

Urban N.Designing early detection programs for ovarian cancer[J]. Ann.Oncol,2011(08):6-18.

Moore RG,Mille MC ,Brown AK ,etal.Utility of tumormarker HE4 to predict depth of myometrial invasion in endimetrioid adenocarcinoma of the uterus[J].Int J Gynecol Cancer,2011(21):1185-1190.

胡晓舟 , 崔丽艳 , 张捷 . 健康人群血清 HE4 水平参考区间的初步探讨 [J]. 中华检验医学杂志 ,2009(12):1376-1378.

涂云霞 , 胡小青 , 华金仁 , 等 . 探讨子宫内膜癌手术病理分期的临床意义 [J]. 当代医学 ,2017(19):149-150.

Stiekema A,Lok C,Korse CM,etal.Serum HE4 is correlated to prognostic factors and survival in patients with endometrial cancer[J]. Virchows Arch,2017(0J6):655-664.

DOI: http://dx.doi.org/10.26549/yzlcyxzz.v3i3.3935